Pfizer Inc. (NYSE:PFE) trending up slowly near short term support

Pfizer Inc. (NYSE:PFE) (TREND ANALYSIS) shares were traded with no significant volume change. The stock closed last trading session at $33.12, up by 0.33%, with a volume of 19,478,614 shares against an average volume for the last 30 days of 20,816,338.

Pfizer Inc. (PFE) reported last quarter earnings figures on May 02nd. The company announced actual earnings per share of $0.69 against the consensus Street estimate of $0.67. This represents a year-on-year increase of earning per share of $0.02 from corresponding quarter of last year. Pfizer Inc. posted revenue of $12.78 billion.

Stock Performance: Click here for a free comprehensive Trend Analysis Report

Pfizer Inc. (PFE) reported last quarter earnings figures on May 02nd. The company announced actual earnings per share of $0.69 against the consensus Street estimate of $0.67. This represents a year-on-year increase of earning per share of $0.02 from corresponding quarter of last year. Pfizer Inc. posted revenue of $12.78 billion.

The company is currently valued at $197.66 billion and closed the last trading session at $33.12. The stock has 50-day moving average of $33.93 and a 200-day moving average of $33.31.

Pfizer Inc. (NYSE:PFE) is currently trading 11.42% below its 52-week-high, 11.03% above its 52-week-low and in the range of $32.8-$34.52 over the past month. The 1-year range for the stock is $29.83-$37.39. Pfizer Inc. (PFE) has a price to book ratio of 3.38 versus S&P 500 average of 3.09. The company’s share price has underperformed the S&P 500 year to date by -4.97%.

Stock Analyst Perspectives: Click here for a free Trend Analysis Report

There are currently twenty-four analysts that we track that cover PFE. Of those twenty-four, twelve have a buy rating, twelve have a hold rating. On a consensus basis this yields to a Buy. The overall consensus target price stands at $37.82 which represents an upside of 14.2% from the last closing price of $33.12.

Recently, several research firms updated their ratings on the stock. Indeed, in the last five days, an average price target of $38.56 has been given to the stock, which represents an upside of 16.41% from the last closing price.

Indeed, Cowen reiterated their outperform stance on May 15th, with a target price of $43, which represents an upside of 29.83% from the last closing price. Another research firm, Piper Jaffray, maintained their overweight stance on the same day, with a target price of $52, which translates into an upside of 57%. Finally, Edward Jones reiterated their buy stance on May 02nd.

Company Profile

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets healthcare products worldwide. The Company’s products include medicines, vaccines, medical devices, and consumer healthcare products.

Related Posts

About The Author